Startups channel feed

Ex­clu­sive: Lil­ly backs a16z-fund­ed Ar­da Ther­a­peu­tic­s' $43M Se­ries A to take AD­Cs in­to fi­bro­sis

7 months ago
Financing

Astel­las places new bet on gene ther­a­py in $50M up­front deal with UK start­up

7 months ago
Deals
Cell/Gene Tx

Mer­ck part­ners with small UK biotech to drug fi­brob­lasts for fi­bro­sis, I&I dis­eases

7 months ago
Deals

Ex­clu­sive: Tiny start­up with big vi­sion to ex­tend healthspan by 20 years says it dis­cov­ered an ‘At­las of Re­ju­ve­na­tion’

7 months ago
Financing

Oak­tree cre­ates third life sci­ences SPAC, fol­low­ing suc­cess with Hims & Hers and Alvotech

7 months ago
Financing

Up­stream and CAMP4 tar­get $182M, $67M IPOs

7 months ago
Financing

Biotech's third quar­ter was rel­a­tive­ly bright — with a few caveats

7 months ago
Financing
Deals

Flag­ship part­ners with key Sin­ga­pore R&D agency as it boosts APAC in­vest­ment

7 months ago
Financing

In­vestor Kur­ma Part­ners rais­es €140M for lat­est Eu­rope-fo­cused biotech fund

7 months ago
Financing

Septer­na files for Nas­daq list­ing as biotech IPOs come to life

7 months ago
Financing

Ex­clu­sive: Af­ter dis­cov­er­ing an­tibi­otics with AI, a 31-year-old first-time CEO rais­es $17M to fight ag­ing

7 months ago
AI

Triveni to take ex­per­i­men­tal eczema drug to the clin­ic, backed by new $115M fi­nanc­ing round

7 months ago
Financing

CAMP4, prepar­ing for IPO, an­nounces part­ner­ship with Bio­Marin

7 months ago
Deals

Ron Re­naud's new obe­si­ty biotech, Kail­era, has $400M to go straight to Phase 3

7 months ago
Financing
China

Met­sera part­ners with Am­neal to man­u­fac­ture obe­si­ty drugs, and Clive Mean­well hands over CEO role

7 months ago
Deals
Manufacturing

En­so­ma shut­ters Copen­hagen site from its Twelve Bio ac­qui­si­tion

7 months ago
People

DCVC Bio reels in $400M third fund

7 months ago
Financing

Rivus de­tails weight loss da­ta in heart fail­ure pa­tients and preps for new fundraise

7 months ago
R&D

Lil­ly-part­nered ra­dio­phar­ma start­up Ak­tis On­col­o­gy rais­es $175M

7 months ago
Financing
Pharma

The End­points 11 win­ners: Big bets on AI, new fron­tiers in edit­ing, a neu­ro re­nais­sance and Chi­nese chem­istry

8 months ago
Special

End­points 11 win­ner MediLink Ther­a­peu­tics: Chi­na start­up helps pow­er the ADC re­nais­sance

8 months ago
Special

End­points 11 win­ner Li­for­di Im­munother­a­peu­tics: Us­ing an­ti­bod­ies to de­liv­er po­tent steroids di­rect­ly to im­mune cells

8 months ago
Special

End­points 11 win­ner Iambic Ther­a­peu­tics: En­ter­ing the ‘show-me’ era for AI

8 months ago
Special

End­points 11 win­ner Car­du­ri­on Phar­ma­ceu­ti­cals: A shot at one of heart dis­ease’s 'un­drug­gable' tar­gets

8 months ago
Special
First page Previous page 891011121314 Next page Last page
A service from the Financial Times